Melinta
is a biotechnology company that develops and commercializes novel antibiotics for the treatment of bacterial infections... Read moreMelinta
is a biotechnology company that develops and commercializes novel antibiotics for the treatment of bacterial infections... Read more
News
Dec 02, 2024
Business Wire
Press Release: Melinta : Melinta Joins NHIA Future of Infusion Advisory Council
Oct 16, 2024
Business Wire
Press Release: Melinta : Melinta Therapeutics Announces IDWeek 2024 Presentations Focused on Melinta's Portfolio of Commercial and Investigational Stage Products
May 23, 2024
Business Wire
Press Release: Melinta : Melinta Therapeutics Announces Publication of the Outcomes by Candida Species from the ReSTORE Phase 3 trial and Recently Approved Rezafungin CLSI Breakpoints for Candida glabrata and Candida auris
Feb 23, 2024
Business Wire
Press Release: Melinta : Venatorx and Melinta Provide Update on Status of U.S. New Drug Application for Cefepime-Taniborbactam
Feb 23, 2024
Endpoints News
Melinta: FDA rejects Melinta, Venatorx's UTI antibiotic over CMC issues
Feb 20, 2024
BioSpace
Melinta: New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3 CERTAIN-1 Study of Patients with Complicated Urinary Tract Infection
Dec 05, 2023
BioSpace
Melinta: Melinta Therapeutics & Cidara Therapeutics Announce Publication of Pooled Data from Phase 3 Pivotal ReSTORE Trial
Nov 22, 2023
Global Legal Chronicle
Melinta: Melinta Therapeutics' Licensing Agreement with Venatorx Pharmaceuticals
Oct 11, 2023
Business Wire
Press Release: Melinta : Melinta Therapeutics Announces Presentations of New Data on Infectious Disease Portfolio at IDWeek 2023
Oct 02, 2023
Acrofan
Melinta: Melinta Therapeutics Announces Expanded Reimbursement and Access for REZZAYO (rezafungin for injection)
Melinta Competitors
1
2
3
4
5
6
7
8
9
10